SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: a systematic review and network meta-analysis
Bao Y, Hu Y, Shi M, Zhao Z
Diabetes Obes Metab. Pub. online 6 Dec 2024.
Leggi